- Pharmacovigilance of Biopharmaceuticals Challenges Remain
[作者:Giezen, TJ; Mantel-Teeuwisse, AK; Leufkens, HGM,期刊:Drug safety, 页码:811-817 , 文章类型: Review,,卷期:2009年32-10]
- Biopharmaceuticals are important treatment options for a variety of chronic and sometimes life-threatening diseases. Compared with the traditional small molecule drugs, biopharmaceuticals have specific characteristics, w...
- The Causes of and Factors Associated with Prescribing Errors in Hospital Inpatients A Systematic Review
[作者:Tully, MP; Ashcroft, DM; Dornan, T; Lewis, PJ; Taylor, D; Wass, V,期刊:Drug safety, 页码:819-836 , 文章类型: Review,,卷期:2009年32-10]
- Prescribing errors are common, they result in adverse events and harm to patients and it is unclear how best to prevent them because recommendations are more often based on surmized rather than empirically collected data...
- Communicating the Risk of Side Effects to Patients An Evaluation of UK Regulatory Recommendations
[作者:Knapp, P; Raynor, DK; Woolf, E; Gardner, PH; Carrigan, N; McMillan, B,期刊:Drug safety, 页码:837-849 , 文章类型: Article,,卷期:2009年32-10]
- Background: All licensed medicines in the European Union must be provided with a Patient Information Leaflet that includes a list of all known side effects. Among patients who read the leaflet, the side effects section i...
|